Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Liquid Biopsy Market Global Forecast by Cancer, Product, Sample, Circulating Biomarkers, Regions, Company Analysis

Published by Renub Research Product code 982535
Published Content info 143 Pages
Delivery time: 1-2 business days
Price
Back to Top
Liquid Biopsy Market Global Forecast by Cancer, Product, Sample, Circulating Biomarkers, Regions, Company Analysis
Published: January 1, 2021 Content info: 143 Pages
Description

A liquid biopsy is an emerging tool for the diagnosis of cancer disease nowadays. The liquid biopsy involves collecting samples and analysing tumours in the blood to diagnose cancer disease in the human body. Liquid biopsy assists medical practitioners as a source of genomic and proteomic knowledge in cancer patients by early detection of circulating tumour cells, DNA and extracellular vesicles. Currently, liquid biopsy plays a critical role in accelerating and implementing accurate oncology in clinical settings by leading to an improved understanding of tumour heterogeneity and allowing for dynamic control of reactions to care and variations in genomics. According to Renub Research analysis, Global Liquid Biopsy Market is expected to be US$ 3.1 Billion by 2026.

The major growth drivers of liquid biopsies are that while extracting the tissue sample from the human body is much pain-free, it substitutes the pain associated with the procedure. Besides, liquid biopsy is very accurate in detecting tumour cells in the blood of cancer patients. Due to the low sensitivity of liquid biopsy, it acts as the restraint factor in the market's growth.

The key players play an essential role in the liquid biopsy market's growth by launching innovative products. In June 2020, NeoGenomics Inc. launched three liquid biopsy tests for non-small cell lung cancer, solid tumour types, and specific breast cancer. The COVID-19 effect in the liquid biopsy market has been harsh because all patients are taking therapies to treat cancer; since they have a weak immune system, and they are less prone to fight with coronavirus diseases.

Renub Research report titled "Liquid Biopsy Market Global Forecast by Cancer (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer & Others), Product (Kits & Consumables, Instruments and Services), Sample (Plasma/Serum, Urine & Others), Circulating Biomarkers (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs) & Exosomes), Clinical Application (Monitoring, Theranostics, Prognosis & Screening), Regions (Europe, North America, Latin America, Asia-Pacific and Middle East/Africa), Companies (Roche Diagnostics, Thermo Fisher Scientific Inc., Biocept Inc., Bio-Rad Laboratories Inc., Genomic Health, Biocartis, Myriad Genetics Inc., Qiagen, NeoGenomics Laboratories)" provides a detailed analysis of Global Liquid Biopsy Industry.

By Cancer

  • 1. Lung Cancer
  • 2. Breast Cancer
  • 3. Colorectal Cancer
  • 4. Prostate Cancer
  • 5. Others

By Product

  • 1. Kits & Consumables
  • 2. Instruments
  • 3. Services

By Circulating Biomarkers

  • 1. Circulating Tumor Cells (CTCs)
  • 2. Circulating Tumor DNA (ctDNA)
  • 3. Extracellular Vesciles
  • 4. Others

By Sample

  • 1. Plasma/Serum
  • 2. Urine
  • 3. Others

By Clinical Application

  • 1. Monitoring
  • 2. Prognosis
  • 3. Theranostics
  • 4. Screening

By Regions

  • 1. North America
  • 2. Europe
  • 3. Asia-Pacific
  • 4. Latin America
  • 5. Middle East/Africa

All the 9 Companies Studied in the Report have been Studied from three Points

  • Company Overview
  • Recent Development
  • Financial Insight

By Companies

  • 1. Thermo Fisher Scientific Inc.
  • 2. Roche Diagnostics
  • 3. Bio-Rad Laboratories Inc.
  • 4. Biocept Inc.
  • 5. Biocartis
  • 6. Myriad Genetics, Inc.
  • 7. Genomic Health
  • 8. NeoGenomics Laboratories
  • 9. Qiagen
Table of Contents

Table of Contents

1. Introduction

2. Executive Summary

3. Market Dynamics

  • 3.1 Growth Drivers
  • 3.2 Challenges

4. Global - Liquid Biopsy Market

5. Market Share - Global Liquid Biopsy

  • 5.1 By Region
  • 5.2 By Cancer
  • 5.3 By Product
  • 5.4 By Circulating Biomarkers

6. Region - Liquid Biopsy Market

  • 6.1 North America
  • 6.2 Europe
  • 6.3 Asia-Pacific
  • 6.4 Latin America
  • 6.5 Middle East & Africa

7. Cancer - Liquid Biopsy Market

  • 7.1 Lung Cancer
  • 7.2 Breast Cancer
  • 7.3 Colorectal Cancer
  • 7.4 Prostate Cancer
  • 7.5 Others

8. By Product - Liquid Biopsy Market

  • 8.1 Kits & Consumables
  • 8.2 Instruments
  • 8.3 Services

9. Circulating Biomarkers - Liquid Biopsy Market

  • 9.1 Circulating Tumor cell (CTCs)
  • 9.2 Circulating Tumor DNA (ctDNA)
  • 9.3 Extracellular Vesicles (Evs)
  • 9.4 Other Biomarkers (cell free DNA,etc)

10. By Clinical Application - Liquid Biopsy Market

  • 10.1 Monitoring
  • 10.2 Prognosis
  • 10.3 Theranostics
  • 10.4 Screening

11. By Sample - Liquid Biopsy Market

  • 11.1 Plasma / Serum
  • 11.2 Urine
  • 11.3 Others

12. Company Analysis

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Overview
    • 12.1.2 Product Portfolio
  • 12.2 Roche Diagnostics
    • 12.2.1 Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Financial Insight
  • 12.3 Bio-Rad Laboratories Inc
    • 12.3.1 Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Financial Insight
  • 12.4 Biocept, Inc.
    • 12.4.1 Overview
    • 12.4.2 Product Portfolio
  • 12.5 Biocartis
    • 12.5.1 Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Financial Insight
  • 12.6 Myriad Genetics, Inc
    • 12.6.1 Overview
    • 12.6.2 Product Portfolio
    • 12.6.3 Financial Insight
  • 12.7 Genomic Health
    • 12.7.1 Product Portfolio
    • 12.7.2 Financial Insight
  • 12.8 NeoGenomics Laboratories
    • 12.8.1 Overview
    • 12.8.2 Product Portfolio
    • 12.8.3 Financial Insight
  • 12.9 Qiagen
    • 12.9.1 Overview
    • 12.9.2 Product Portfolio
    • 12.9.3 Financial Insight

List of Figures

  • Figure 4-1: Global - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 4-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 5-1: By Region - Liquid Biopsy Market Share (%), 2015 - 2020
  • Figure 5-2: By Region - Forecast for Liquid Biopsy Market Share (%), 2021 - 2026
  • Figure 5-3: By Cancer - Liquid Biopsy Market Share (%), 2015 - 2020
  • Figure 5-4: By Cancer - Forecast for Liquid Biopsy Market Share (%), 2021 - 2026
  • Figure 5-5: By Product - Liquid Biopsy Market Share (%), 2015 - 2020
  • Figure 5-6: By Product - Forecast for Liquid Biopsy Market Share (%), 2021 - 2026
  • Figure 5-7: By Circulating Biomarkers - Liquid Biopsy Market Share (%), 2015 - 2020
  • Figure 5-8: By Circulating Biomarkers - Forecast for Liquid Biopsy Market Share (%), 2021 - 2026
  • Figure 6-1: United States Cancers by rates of New Cancer Cases (Male & Female) - 2015
  • Figure 6-2: United States Cancers by rates of Cancer Deaths (Male & Female) - 2015
  • Figure 6-3: Number of cancer deaths in Mexico in 2018, by cancer type (in Thousands)
  • Figure 6-4: North America - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 6-5: North America - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 6-6: Europe - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 6-7: Europe - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 6-8: Asia-Pacific - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 6-9: Asia-Pacific - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 6-10: Latin America - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 6-11: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 6-12: Middle East & Africa - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 6-13: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 7-1: Lung Cancer - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 7-2: Lung Cancer - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 7-3: Breast Cancer - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 7-4: Breast Cancer - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 7-5: Colorectal Cancer - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 7-6: Colorectal Cancer - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 7-7: Prostate Cancer - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 7-8: Prostate Cancer - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 7-9: Others - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 7-10: Others - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 8-1: Kits & Consumables - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 8-2: Kits & Consumables - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 8-3: Instruments - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 8-4: Instruments - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 8-5: Services - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 8-6: Services - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 9-1: CTCs - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 9-2: CTCs - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 9-3: ctDNA - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 9-4: ctDNA - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 9-5: Extracellular Vesicles - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 9-6: Extracellular Vesicles - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 9-7: Other Biomarkers - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 9-8: Other Biomarkers - Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 10-1: Monitoring - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 10-2: Monitoring - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 10-3: Prognosis - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 10-4: Prognosis - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 10-5: Theranostics - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 10-6: Theranostics - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 10-7: Screening - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 10-8: Screening - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 11-1: Plasma/Serum - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 11-2: Plasma/Serum - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 11-3: Urine - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 11-4: Urine - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 11-5: Others - Liquid Biopsy Market (Million US$), 2015 - 2020
  • Figure 11-6: Others - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2026
  • Figure 12-1: Roche Diagnostics - Diagnostics Sales (Million US$), 2015 - 2020
  • Figure 12-2: Roche Diagnostics - Forecast for Diagnostics Sales (Billion US$), 2021 - 2026
  • Figure 12-3: Bio-Rad Laboratories - Net Sales (Million US$), 2015 - 2020
  • Figure 12-4: Bio-Rad Laboratories - Forecast for Net Sales (Million US$), 2021 - 2026
  • Figure 12-5: Biocept - Revenue (Million US$), 2015 - 2020
  • Figure 12-6: Biocept - Forecast for Revenue (Million US$), 2021 - 2026
  • Figure 12-7: Biocartis - Net Sales (Million US$), 2015 - 2020
  • Figure 12-8: Biocartis - Forecast for Net Sales (Million US$), 2021 - 2027
  • Figure 12-9: Myriad Genetics - Molecular Diagnostics Revenue (Million US$), 2015 - 2020
  • Figure 12-10: Myriad Genetics - Forecast for Molecular Diagnostics Revenue (Million US$), 2021 - 2026
  • Figure 12-11: NeoGenomics Laboratories - Net Sales (Million US$), 2015 - 2020
  • Figure 12-12: NeoGenomics Laboratories - Forecast for Net Sales (Million US$), 2021 - 2027
  • Figure 12-13: Qiagen - Revenue (Million US$), 2015 - 2020
  • Figure 12-14: Qiagen - Forecast For Revenue (Million US$), 2021 - 2027

List of Tables

  • Table 6-1: Estimated number of people living with cancer: by nation, at the end of 2010, 2015, 2020 and 2030
  • Table 6-2: Cancer Statistics Japan - 2017
Back to Top